RxDoctor Payments Data

Doug Vermillion, MD

Orthopaedic Surgery · Anchorage, AKNPI 1336114388

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (45.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Stryker at 37.9% of the total. Reporting peaked in 2022 at $2,900 and has fallen 80.6% since, to $562 in 2025.

$6,485in general payments, 2019–2025

Across 87 payments — averaging $74.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Summit Surgical Corp.$1K
  • Encore Medical, LP$563
  • Johnson & Johnson$382
  • Smith+Nephew$214
  • Pacira Pharmaceuticals Incorporated$209
  • plus $1K from 15 others

What the payments were for

  • Travel & lodging$2,25635%
  • Food & beverage$2,91945%
  • Education$1,31020%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,485 in reported general payments places this provider in the 65th percentile of 63 orthopaedic surgery providers in Alaska.

See all orthopaedic surgery providers in Alaska

Medicare billing

Part B allowed, 2024
$87,420
Medicare patients
127
Services billed
3,992

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron11$76
Oxycodone Hcl12$68

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →